HCCI’s President and CEO Niall Brennan was quoted in a Kaiser Health News article on the CMS Transparency in Coverage Final Rule.
From the article:
” ‘If the information is presented to consumers so they realize they are paying a higher price without the benefit of the rebates, you’ll get a lot of angry consumers,’ said Niall Brennan, CEO of the Health Care Cost Institute, a nonprofit group that publishes cost data.”
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs | Kaiser Health News
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.